Exploring High Growth Tech Stocks In Europe May 2025

In This Article:

As European markets continue to navigate the complexities of global trade tensions, the pan-European STOXX Europe 600 Index has shown resilience, rising for a fourth consecutive week amid optimism for easing U.S.-China trade disputes. In this environment, high-growth tech stocks in Europe are capturing attention as investors seek opportunities that align with strong industrial output and favorable monetary policies; these stocks often exhibit innovative capabilities and robust growth potential even amidst broader market uncertainties.

Top 10 High Growth Tech Companies In Europe

Name

Revenue Growth

Earnings Growth

Growth Rating

Digital Value

29.11%

29.54%

★★★★★★

KebNi

21.29%

66.10%

★★★★★★

Bonesupport Holding

29.14%

56.14%

★★★★★★

Pharma Mar

25.21%

43.09%

★★★★★★

Yubico

20.18%

30.36%

★★★★★★

Elicera Therapeutics

63.53%

97.24%

★★★★★★

Ascelia Pharma

43.57%

77.62%

★★★★★★

Elliptic Laboratories

23.60%

51.89%

★★★★★★

CD Projekt

33.48%

37.39%

★★★★★★

Norbit

20.46%

26.58%

★★★★★★

Click here to see the full list of 223 stocks from our European High Growth Tech and AI Stocks screener.

Here's a peek at a few of the choices from the screener.

Pharma Mar

Simply Wall St Growth Rating: ★★★★★★

Overview: Pharma Mar, S.A. is a biopharmaceutical company focused on the research, development, production, and commercialization of bio-active principles for oncology across various international markets with a market cap of approximately €1.31 billion.

Operations: The company generates revenue primarily from its oncology segment, totaling €178.70 million.

Pharma Mar's trajectory in the high-growth tech sector is underscored by a robust annual revenue growth rate of 25.2% and an even more impressive earnings growth forecast at 43.1% per year. This performance outpaces the broader Spanish market significantly, where average earnings growth hovers around 5.2%. Notably, its R&D commitment is reflected in its substantial investment, aligning with recent strategic moves including a proposed dividend increase and multiple high-profile conference presentations that could bolster its industry standing and innovation pipeline.

BME:PHM Revenue and Expenses Breakdown as at May 2025
BME:PHM Revenue and Expenses Breakdown as at May 2025

Bittium Oyj

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Bittium Oyj offers communications and connectivity solutions, healthcare technology products and services, and biosignal measuring and monitoring across Finland, Germany, and the United States with a market capitalization of €229.60 million.